{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:20:46Z","timestamp":1788888046557,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007332","name":"Autism Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autism Spectrum Disorder (ASD) is a set of heterogeneous neurodevelopmental conditions defined by impairments in social communication and restricted, repetitive behaviors, interests or activities. Only a minority of ASD cases are determined to have a definitive etiology and the pathogenesis of most ASD is poorly understood. We hypothesized that a global analysis of the proteomes of human ASD vs. control brain, heretofore not done, would provide important data with which to better understand the underlying neurobiology of autism. In this study, we characterized the proteomes of two brain regions, Brodmann area 19 (BA19) and posterior inferior cerebellum (CB), from carefully selected idiopathic ASD cases and matched controls using label-free HPLC-tandem mass spectrometry. The data revealed marked differences between ASD and control brain proteomes for both brain regions. Unlike earlier transcriptomic analyses using frontal and temporal cortex, however, our proteomic analysis did not support ASD attenuating regional gene expression differences. Bioinformatic analyses of the differentially expressed proteins between cases and controls highlighted canonical pathways involving glutamate receptor signaling and glutathione-mediated detoxification in both BA19 and CB; other pathways such as Sertoli cell signaling and fatty acid oxidation were specifically enriched in BA19 or CB, respectively. Network analysis of both regions of ASD brain showed up-regulation of multiple pre- and post-synaptic membrane or scaffolding proteins including glutamatergic ion channels and related proteins, up-regulation of proteins involved in intracellular calcium signaling, and down-regulation of neurofilament proteins, with DLG4 and MAPT as major hub proteins in BA19 and CB protein interaction networks, respectively. Upstream regulator analysis suggests neurodegeneration-associated proteins drive the differential protein expression for ASD in both BA19 and CB. Overall, the proteomic data provide support for shared dysregulated pathways and upstream regulators for two brain regions in human ASD brain, suggesting a common ASD pathophysiology that has distinctive regional expression.<\/jats:p>","DOI":"10.1038\/s41598-019-49533-y","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T06:03:02Z","timestamp":1568181782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Proteomic Investigations of Autism Brain Identify Known and Novel Pathogenetic Processes"],"prefix":"10.1038","volume":"9","author":[{"given":"Joseph R.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Szoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2403-8268","authenticated-orcid":false,"given":"John","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schlatzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin R.","family":"Natowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"49533_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"M-C Lai","year":"2014","unstructured":"Lai, M.-C., Lombardo, M. V. & Baron-Cohen, S. Autism. Lancet 383, 896\u2013910 (2014).","journal-title":"Lancet"},{"key":"49533_CR2","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","volume":"392","author":"C Lord","year":"2018","unstructured":"Lord, C., Elsabbagh, M., Baird, G. & Veenstra-Vanderweede, J. Autism spectrum disorder. Lancet 392, 508\u2013520 (2018).","journal-title":"Lancet"},{"key":"49533_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.nurt.2010.06.001","volume":"7","author":"ML Bauman","year":"2010","unstructured":"Bauman, M. L. Medical comorbidities in autism: challenges to diagnosis and treatment. Neurotherapeutics 7, 320\u2013327 (2010).","journal-title":"Neurotherapeutics"},{"key":"49533_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00787-017-1020-0","volume":"26","author":"JB Muskens","year":"2017","unstructured":"Muskens, J. B., Velders, F. P. & Staal, W. G. Medical comorbidities in children and adolescents with autism spectrum disorders and atttention deficit hyperactivity disorders: a systematic review. Eur Child Adolesc Psychiatry 26, 1093\u20131103 (2017).","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"49533_CR5","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 disease and injury incidence and prevalence collaborators","year":"2018","unstructured":"GBD 2017 disease and injury incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789\u20131858 (2018).","journal-title":"Lancet"},{"key":"49533_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamapediatrics.2014.210","volume":"168","author":"AVS Buescher","year":"2014","unstructured":"Buescher, A. V. S., Cidav, Z., Knapp, M. & Mandell, D. S. Costs of Autism Spectrum Disorders in the United Kingdom and the United States. JAMA Pediatr 168, 721\u2013728 (2014).","journal-title":"JAMA Pediatr"},{"key":"49533_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","volume":"5","author":"M Elsabbagh","year":"2012","unstructured":"Elsabbagh, M. et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 5, 160\u2013172 (2012).","journal-title":"Autism Res"},{"key":"49533_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-publhealth-031816-044318","volume":"38","author":"K Lyall","year":"2017","unstructured":"Lyall, K. et al. The changing epidemiology of autism spectrum disorders. Annu Rev Public Health 38, 81\u2013102 (2017).","journal-title":"Annu Rev Public Health"},{"key":"49533_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.brainres.2010.11.078","volume":"1380","author":"C Betancur","year":"2011","unstructured":"Betancur, C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380, 42\u201377 (2011).","journal-title":"Brain Res"},{"key":"49533_CR10","doi-asserted-by":"crossref","unstructured":"Kleijer, K. T. E., Huguet, G., Tastet, J., Bourgeron, T. & Burbach, J. P. H. Anatomy and cell biology of Autism Spectrum Disorder: lessons from human genetics. Translational Anatomy and Cell Biology of Autism Spectrum Disorder, Advances in Anatomy, Embryology and Cell Biology, Springer, pp 1\u201325 (2017).","DOI":"10.1007\/978-3-319-52498-6_1"},{"key":"49533_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13229-016-0103-y","volume":"7","author":"E Larsen","year":"2016","unstructured":"Larsen, E. et al. A systematic variant annotation approach for ranking genes associated with autism spectrum disorders. Molec Autism 7, 44 (2016).","journal-title":"Molec Autism"},{"key":"49533_CR12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00018-018-2988-4","volume":"76","author":"S B\u00f6lte","year":"2019","unstructured":"B\u00f6lte, S., Girdler, S. & Marschik, P. B. The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol Life Sci 76, 1275\u20131297 (2019).","journal-title":"Cell Mol Life Sci"},{"key":"49533_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2018.00001","volume":"9","author":"LE Gialloret","year":"2018","unstructured":"Gialloret, L. E. & Curatolo, P. Autism Spectrum Disorder: why do we know so little? Front Neurol 9, 1\u20134 (2018).","journal-title":"Front Neurol"},{"key":"49533_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.conb.2007.01.009","volume":"17","author":"DH Geschwind","year":"2007","unstructured":"Geschwind, D. H. & Levitt, P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 17, 103\u2013111 (2007).","journal-title":"Curr Opin Neurobiol"},{"key":"49533_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrn3992","volume":"16","author":"T Bourgeron","year":"2015","unstructured":"Bourgeron, T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci 16, 551\u2013563 (2015).","journal-title":"Nat Rev Neurosci"},{"key":"49533_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.neuron.2016.02.017","volume":"89","author":"C Mullins","year":"2016","unstructured":"Mullins, C., Fishell, G. & Tsien, R. W. Unifying views of Autism Spectrum Disorders: a consideration of autoregulatory feedback loops. Neuron 89, 1131\u20131156 (2016).","journal-title":"Neuron"},{"key":"49533_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/nn.4420","volume":"19","author":"Y Sztainberg","year":"2016","unstructured":"Sztainberg, Y. & Zoghbi, H. Y. Lessons learned from studying syndromic autism spectrum disorders. Nat Neurosci 19, 1408\u20131417 (2016).","journal-title":"Nat Neurosci"},{"key":"49533_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nm.4071","volume":"22","author":"L de la Torre-Ubieta","year":"2016","unstructured":"de la Torre-Ubieta, L., Won, H., Stein, J. L. & Geschwind, D. H. Advancing the understanding of autism disease mechanisms through genetics. Nat Med 22, 345\u2013361 (2016).","journal-title":"Nat Med"},{"key":"49533_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.conb.2017.05.018","volume":"45","author":"F Hollis","year":"2017","unstructured":"Hollis, F., Kanellopoulos, A. & Bagni, C. Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives. Curr Opin Neurobiol 45, 178\u2013187 (2017).","journal-title":"Curr Opin Neurobiol"},{"key":"49533_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3390\/ijms18040828","volume":"18","author":"O Oron","year":"2017","unstructured":"Oron, O. & Elliott, E. Delineating the common biological pathways perturbed by ASD\u2019s genetic etiology: lessons from network-based studies. Int J Molec Sci 18, 828 (2017).","journal-title":"Int J Molec Sci"},{"key":"49533_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41576-018-0066-2","volume":"20","author":"M Quesnel-Vallieres","year":"2019","unstructured":"Quesnel-Vallieres, M., Weatheritt, R. J., Cordes, S. P. & Biencowe, B. J. Autism spectrum disorder: insights into convergent mechanisms from transcriptomics. Nat Rev Genet 20, 51\u201363 (2019).","journal-title":"Nat Rev Genet"},{"key":"49533_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold, R. & Mann, M. Mass-spectrometric exploration of proteome structure and function. Nature 537, 347\u2013355 (2016).","journal-title":"Nature"},{"key":"49533_CR23","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/pmic.201600203","volume":"16","author":"R Aebersold","year":"2016","unstructured":"Aebersold, R., Bensimon, A., Collins, B. C., Ludwig, C. & Sabido, E. Applications and developments in targeted proteomics: from SRM to DIA\/SWATH. Proteomics 16, 2065\u20132067 (2016).","journal-title":"Proteomics"},{"key":"49533_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.neuron.2017.09.025","volume":"96","author":"F Hosp","year":"2017","unstructured":"Hosp, F. & Mann, M. A primer on concepts and applications of proteomics in neuroscience. Neuron 96, 558\u2013571 (2017).","journal-title":"Neuron"},{"key":"49533_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-3-030-05542-4_12","volume":"1118","author":"J Abraham","year":"2019","unstructured":"Abraham, J., Szoko, N. & Natowicz, M. R. Proteomic investigations of Autism Spectrum Disorder: past findings, current challenges, and future prospects. Adv Exp Med Biol 1118, 235\u2013252 (2019).","journal-title":"Adv Exp Med Biol"},{"key":"49533_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/B978-0-444-64189-2.00004-4","volume":"155","author":"MMK Bruchhage","year":"2018","unstructured":"Bruchhage, M. M. K., Bucci, M. P. & Becker, E. B. E. Cerebellar involvement in autism and ADHD. Handb Clin Neurol 155, 61\u201372 (2018).","journal-title":"Handb Clin Neurol"},{"key":"49533_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000076719","volume":"49","author":"EA Hazlett","year":"2004","unstructured":"Hazlett, E. A. et al. Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patients. Neuropsychobiology 49, 115\u2013125 (2004).","journal-title":"Neuropsychobiology"},{"key":"49533_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.nicl.2014.02.008","volume":"4","author":"M-R Poulin-Lord","year":"2014","unstructured":"Poulin-Lord, M.-R. et al. Increased topographical variability of task-related activation in perceptive and motor associative regions in adult autistics. NeuroImage 4, 444\u2013453 (2014).","journal-title":"NeuroImage"},{"key":"49533_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6748","volume":"5","author":"S Gupta","year":"2014","unstructured":"Gupta, S. et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun 5, 5748 (2014).","journal-title":"Nat Commun"},{"key":"49533_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10110","volume":"474","author":"I Voineagu","year":"2011","unstructured":"Voineagu, I. et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474, 380\u2013384 (2011).","journal-title":"Nature"},{"key":"49533_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nature20612","volume":"540","author":"NN Parikshak","year":"2016","unstructured":"Parikshak, N. N. et al. Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism. Nature 540, 423\u2013427 (2016).","journal-title":"Nature"},{"key":"49533_CR32","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.pbb.2011.06.023","volume":"100","author":"PR Choudhury","year":"2012","unstructured":"Choudhury, P. R., Lahiri, S. & Fajama, U. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharm Biochem Behav 100, 841\u2013849 (2012).","journal-title":"Pharm Biochem Behav"},{"key":"49533_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.pnpbp.2017.09.014","volume":"84","author":"E Moretto","year":"2018","unstructured":"Moretto, E., Murru, L., Martano, G., Sassone, J. & Passafaro, M. Glutamatergic synapses in neurodevelopmental disorders. Prog Neurophysch Biol Psychiatr 84, 328\u2013342 (2018).","journal-title":"Prog Neurophysch Biol Psychiatr"},{"key":"49533_CR34","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s11064-012-0775-4","volume":"37","author":"A Chauhan","year":"2012","unstructured":"Chauhan, A., Audhya, T. & Chauha, V. Brain region-specific glutathione redox imbalance in autism. Neurochemical Res 37, 1681\u20131689 (2012).","journal-title":"Neurochemical Res"},{"key":"49533_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.61","volume":"2","author":"S Rose","year":"2012","unstructured":"Rose, S. et al. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2, e134 (2012).","journal-title":"Transl Psychiatry"},{"key":"49533_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2217\/bmm.13.158","volume":"8","author":"RE Frye","year":"2014","unstructured":"Frye, R. E. & James, S. J. Metabolic pathology of autism in relation to redox metabolism. Biomark Med 8, 321\u2013330 (2014).","journal-title":"Biomark Med"},{"key":"49533_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.72","volume":"2","author":"MW Pankhurst","year":"2012","unstructured":"Pankhurst, M. W. & McLennan, I. S. Inhibin B and anti-M\u00fcllerian hormone\/M\u00fcllerian inhibiting substance may contribute to the male bias in autism. Transl Psychiatry 2, e148 (2012).","journal-title":"Transl Psychiatry"},{"key":"49533_CR38","doi-asserted-by":"publisher","first-page":"e1001081","DOI":"10.1371\/journal.pbio.1001081","volume":"9","author":"S Baron-Cohen","year":"2011","unstructured":"Baron-Cohen, S. et al. Why are autism spectrum conditions more prevalent in males? PLoS Biol 9, e1001081 (2011).","journal-title":"PLoS Biol"},{"key":"49533_CR39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1126\/science.1224631","volume":"338","author":"G Novarino","year":"2012","unstructured":"Novarino, G. et al. Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science 338, 394\u2013397 (2012).","journal-title":"Science"},{"key":"49533_CR40","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","volume":"167","author":"DC Tarlungeanu","year":"2016","unstructured":"Tarlungeanu, D. C. et al. Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell 167, 1481\u20131494 (2016).","journal-title":"Cell"},{"key":"49533_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopsych.2018.08.016","volume":"85","author":"AM Smith","year":"2019","unstructured":"Smith, A. M. et al. Amino acid dysregulation metabotypes: potential biomarkers for diagnosis and individualized treatment for subtypes of autism spectrum disorder. Biol Psychiatry 85, 345\u2013354 (2019).","journal-title":"Biol Psychiatry"},{"key":"49533_CR42","first-page":"187","volume":"82","author":"AA Coley","year":"2018","unstructured":"Coley, A. A. & Gao, W.-J. PSD95: a synaptic protein implicated in schizophrenia or autism? Prog Neuropsycholpharmacol. Biol Psychiatry 82, 187\u2013194 (2018).","journal-title":"Biol Psychiatry"},{"key":"49533_CR43","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1007\/s12035-015-9415-8","volume":"53","author":"C-C Zhang","year":"2016","unstructured":"Zhang, C.-C., Xing, A., Tan, M.-S., Tan, L. & Yu, J.-T. The role of MAPT in neurodegenerative diseases: genetics, mechanisms and therapy. Mol Neurobiol 53, 4893\u20134904 (2016).","journal-title":"Mol Neurobiol"},{"key":"49533_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1326-1-4","volume":"1","author":"KS Vetrivel","year":"2006","unstructured":"Vetrivel, K. S., Zhang, Y. W., Xu, H. & Thinakaran, G. Pathological and physiological functions of presinilins. Mol Neurodegen 1, 4 (2006).","journal-title":"Mol Neurodegen"},{"key":"49533_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC M\u00fcller","year":"2017","unstructured":"M\u00fcller, U. C., Deller, T. & Korte, M. Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci 18, 281\u2013298 (2017).","journal-title":"Nat Rev Neurosci"},{"key":"49533_CR46","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou, F. & Humbert, S. The biology of huntingtin. Neuron 89, 910\u2013926 (2016).","journal-title":"Neuron"},{"key":"49533_CR47","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.celrep.2015.04.030","volume":"11","author":"F Hosp","year":"2015","unstructured":"Hosp, F. et al. Quantitative interaction proteomics of neurodegenerative disease proteins. Cell Rep 11, 1134\u20131146 (2015).","journal-title":"Cell Rep"},{"key":"49533_CR48","first-page":"149","volume":"11","author":"JKT Wang","year":"2017","unstructured":"Wang, J. K. T., Langfelder, P., Horvath, S. & Palazzolo, M. J. Exosomes and homeostatic synaptic plasticity are linked to each other and to Huntington\u2019s, Parkinson\u2019s, and other neurodegenerative diseases by database-enabled analyses of comprehensively curated datasets. Front Neurosci 11, 149 (2017).","journal-title":"Front Neurosci"},{"key":"49533_CR49","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","volume":"21","author":"L Gan","year":"2018","unstructured":"Gan, L., Cookson, M. R., Petrucelli, L. & LaSpada, A. R. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci 21, 1300\u20131309 (2018).","journal-title":"Nat Neurosci"},{"key":"49533_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.nbd.2008.01.012","volume":"30","author":"KA Garbett","year":"2008","unstructured":"Garbett, K. A. et al. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30, 303\u2013311 (2008).","journal-title":"Neurobiol Dis"},{"key":"49533_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/2040-2392-3-12","volume":"3","author":"A Anitha","year":"2012","unstructured":"Anitha, A. et al. Brain region-specific altered expression and association of mitochondria-related genes in autism. Mol Autism 3, 12 (2012).","journal-title":"Mol Autism"},{"key":"49533_CR52","doi-asserted-by":"publisher","first-page":"e1002592","DOI":"10.1371\/journal.pgen.1002592","volume":"8","author":"ML Chow","year":"2012","unstructured":"Chow, M. L. et al. Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages. PLoS Genet 8, e1002592 (2012).","journal-title":"PLoS Genet"},{"key":"49533_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/srep01831","volume":"3","author":"MR Ginsberg","year":"2013","unstructured":"Ginsberg, M. R., Rubin, R. A. & Natowicz, M. R. Patterning of regional gene expression in autism: new complexity. Sci Rep 3, 1831 (2013).","journal-title":"Sci Rep"},{"key":"49533_CR54","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/aur.1803","volume":"10","author":"N Szoko","year":"2017","unstructured":"Szoko, N., McShane, A. J. & Natowicz, M. R. Proteomic explorations of autism spectrum disorder. Autism Res 10, 1460\u20131469 (2017).","journal-title":"Autism Res"},{"key":"49533_CR55","doi-asserted-by":"publisher","first-page":"e44736","DOI":"10.1371\/journal.pone.0044736","volume":"7","author":"MR Ginsberg","year":"2012","unstructured":"Ginsberg, M. R., Rubin, R. A., Falcone, T., Ting, A. H. & Natowicz, M. R. Brain transcriptional and epigenetic associations with autism. PLoS One 7, e44736 (2012).","journal-title":"PLoS One"},{"key":"49533_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/aur.173","volume":"4","author":"RF Wintle","year":"2011","unstructured":"Wintle, R. F. et al. A genotype resource for postmortem brain samples from the Autism Tissue Program. Autism Res 4, 89\u201397 (2011).","journal-title":"Autism Res"},{"key":"49533_CR57","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2015.11.009","volume":"88","author":"AM D\u2019Gama","year":"2015","unstructured":"D\u2019Gama, A. M. et al. Targeted DNA sequencing from autism spectrum disorder brains implicates multiple genetic mechanisms. Neuron 88, 910\u2013917 (2015).","journal-title":"Neuron"},{"key":"49533_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-8695-8_1","volume":"1841","author":"JR Wisniewski","year":"2018","unstructured":"Wisniewski, J. R. Filter-aided sample preparation for proteome analysis. Methods Mol Biol 1841, 3\u201310 (2018).","journal-title":"Methods Mol Biol"},{"key":"49533_CR59","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1002\/pmic.201400496","volume":"15","author":"SE Tomechko","year":"2015","unstructured":"Tomechko, S. E. et al. Proteomic and bioinformatics profile of paired human alveolar macrophages and peripheral blood monocytes. Proteomics 15, 3797\u20133805 (2015).","journal-title":"Proteomics"},{"key":"49533_CR60","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1021\/pr700705u","volume":"7","author":"H Neubert","year":"2008","unstructured":"Neubert, H. et al. Label-free detection of differential protein expression by LC\/MALDI mass spectrometry. J Proteome Res 7, 2270\u20132279 (2008).","journal-title":"J Proteome Res"},{"key":"49533_CR61","doi-asserted-by":"crossref","unstructured":"Schlatzer, D. M., Sugalski, J., Dazard, J. E., Chance, M. R. & Anthony D. D. A quantitative proteomic approach for detecting protein profiles of activated human myeloid dendritic cells. J Immunol Meth 375, 39\u201345 37 (2012).","DOI":"10.1016\/j.jim.2011.09.004"},{"key":"49533_CR62","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/bioinformatics\/17.6.520","volume":"17","author":"O Troyanskaya","year":"2001","unstructured":"Troyanskaya, O. et al. Missing value estimation methods for DNA microarrays. Bioinformatics 17, 520\u2013525 (2001).","journal-title":"Bioinformatics"},{"key":"49533_CR63","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/bioinformatics\/btn217","volume":"24","author":"AD Polpitiya","year":"2008","unstructured":"Polpitiya, A. D. et al. DAnTE: a statistical tool for quantitative analysis of omics data. Bioinformatics 24, 1556\u20131558 (2008).","journal-title":"Bioinformatics"},{"key":"49533_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., Maechler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J Statistical Software 67, 1\u201348 (2015).","journal-title":"J Statistical Software"},{"key":"49533_CR65","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Society Series B (Methodological) 57, 289\u2013300 (1995).","journal-title":"J Royal Stat Society Series B (Methodological)"},{"key":"49533_CR66","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1074\/mcp.M800558-MCP200","volume":"8","author":"DM Schlatzer","year":"2009","unstructured":"Schlatzer, D. M. et al. Urinary protein profiles in a rat model for diabetic complications. Mol Cell Proteomics 8, 2145\u20132158 (2009).","journal-title":"Mol Cell Proteomics"},{"key":"49533_CR67","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucl Acids Res 47, D442\u2013D450 (2019).","journal-title":"Nucl Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49533-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49533-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49533-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:29:07Z","timestamp":1671265747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49533-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49533"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49533-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"21 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.R.N. is on the Scientific Advisory Board and has equity in Stemina Biomarker Discovery. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13118"}}